| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/1993 | CA2092768A1 Protein with bone formation ability and process for its production |
| 09/28/1993 | CA2092069A1 An expression plasmid for seeds |
| 09/27/1993 | CA2091544A1 Stabilization of functional proteins |
| 09/24/1993 | WO1993019185A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 09/24/1993 | CA2132420A1 Recombinant antigen containing in its sequence a heterologous immuno-stimulatory domain-use as a vaccine |
| 09/24/1993 | CA2092048A1 Immobilization of biochemical substances |
| 09/24/1993 | CA2092036A1 Immobilization of biochemical substances |
| 09/23/1993 | DE4209216A1 Humaner t-zell-marker ht6 Human t-cell marker HT6 |
| 09/23/1993 | DE4208923A1 Antirheumatic and antiinflammatory agent - comprising mixt. cpds. contg. aminoacid(s), isolated from bacteria or plants, esp. Helleborus, with long lasting action at low doses |
| 09/23/1993 | DE4208634A1 DNA and poly:peptide(s) encoding the pheromone aphrodisine - used in potency and fertility treatment |
| 09/22/1993 | EP0561639A1 Cyclic peptide antifungal agents and process for preparation thereof |
| 09/22/1993 | EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use |
| 09/22/1993 | EP0561523A2 Sugar compound, sialic acid-containing sugar chains' biosynthesis inhibitor, production process thereof and intermediate |
| 09/22/1993 | EP0561496A2 cDNAs encoding the gastrin and CCK-B receptors |
| 09/22/1993 | EP0561429A1 Method of preparing crystalline GM-CSF |
| 09/22/1993 | EP0561427A1 Monoclonal antibodies to new factor VIII coagulant polypeptides |
| 09/22/1993 | EP0561412A1 Parathyroid hormone derivatives |
| 09/22/1993 | EP0561297A2 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 09/22/1993 | EP0561245A1 Blood substitutes comprising recombinant hemoglobin |
| 09/22/1993 | EP0561172A1 Recombinant DNA Clone Encoding Laminin Receptor |
| 09/22/1993 | EP0561140A1 Methods for pharmacokinetical studies of insulin expression involving transgenic mammal |
| 09/22/1993 | EP0561137A1 Hybrid DNA Synthesis of Mature Insulin-like Growth Factors |
| 09/22/1993 | EP0561130A1 Stabilized biologically active polypeptide and use thereof |
| 09/22/1993 | EP0561087A1 Mutated form of the beta-amyloid precursor protein gene |
| 09/22/1993 | EP0561034A2 Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome |
| 09/22/1993 | EP0560998A1 Medicine for preventing and treating bleeding tendency |
| 09/22/1993 | EP0560969A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 09/22/1993 | EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins |
| 09/22/1993 | EP0560929A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 09/22/1993 | EP0560924A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 09/22/1993 | EP0560913A1 Bifunctional inhibitors of thrombin and platelet activation |
| 09/22/1993 | EP0560807A1 Immunoglobulin-binding proteins and recombinant dna molecules coding therefor |
| 09/22/1993 | EP0560776A1 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses |
| 09/22/1993 | EP0546022A4 High viscosity bacteria, bacterial compositions, and methods |
| 09/22/1993 | CN1076489A Genetic sequences for a 90k tumorassociated antigen, ir-95 |
| 09/21/1993 | US5247070 N-terminal muteins of tumor necrosis factor |
| 09/21/1993 | US5247069 Ligands and methods for augmenting B-cell proliferation |
| 09/21/1993 | US5247068 Polyamino acid superabsorbents |
| 09/21/1993 | US5247067 Polypeptides for hepatitis antigens |
| 09/21/1993 | US5246921 Method for treating leukemias |
| 09/21/1993 | US5246852 Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 09/21/1993 | US5246851 Neisseria diagnosis and binding |
| 09/21/1993 | US5246844 Detection of Lyme disease |
| 09/21/1993 | US5246839 Transformation; genetic engineering |
| 09/21/1993 | US5246830 Enzymatic process for the determination of β-lactam antibiotics |
| 09/21/1993 | US5246715 Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
| 09/21/1993 | US5246701 Antiallergens |
| 09/21/1993 | US5246699 Maturation of hemopoietic cells |
| 09/21/1993 | US5246691 Antitumor |
| 09/21/1993 | US5246558 Chondroitin sulfate in agarose gel, electrophoresis and sampling |
| 09/21/1993 | US5245896 Quick-change tool holder with center height adjustment mechanism |
| 09/21/1993 | CA1322342C Molecular cloning and clones of human b lymphotropic virus (hblv) |
| 09/21/1993 | CA1322280C Non-intrusive process for monitoring the production of recombinant proteins |
| 09/20/1993 | CA2091971A1 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 09/20/1993 | CA2091806A1 Insv resistant plants |
| 09/19/1993 | CA2090303A1 Process for the expression of herpes simplex virus type 1 glycoprotein 1 and methods of use |
| 09/17/1993 | CA2091650A1 Processes |
| 09/16/1993 | WO1993018185A1 Receptor internalization signals |
| 09/16/1993 | WO1993018184A1 Detection of trisomy 21; materials and methods |
| 09/16/1993 | WO1993018181A1 Synthetic gene sequence for a signal peptide |
| 09/16/1993 | WO1993018179A1 Bacteriocin from pediococcus cerevisiae |
| 09/16/1993 | WO1993018178A1 DIAGNOSIS OF β-THALASSEMIA USING A MULTIPLEX AMPLIFICATION REFRACTORY MUTATION SYSTEM |
| 09/16/1993 | WO1993018171A1 Control of male fertility using externally inducible promoter sequences |
| 09/16/1993 | WO1993018170A1 Root knot nematode resistance |
| 09/16/1993 | WO1993018167A1 A method for production of proteins in yeast |
| 09/16/1993 | WO1993018165A1 Microorganisms having attenuated invasiveness |
| 09/16/1993 | WO1993018163A2 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | WO1993018162A1 Pathogen-targeted biocatalyst |
| 09/16/1993 | WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | WO1993018160A1 Anti-viral fusion peptides |
| 09/16/1993 | WO1993018153A1 Vaccinia virus b15r used in interleukin b1-involving condition |
| 09/16/1993 | WO1993018152A1 Mn gene and protein |
| 09/16/1993 | WO1993018150A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | WO1993018149A1 Self-incompatibility alleles of brassica |
| 09/16/1993 | WO1993018148A2 Tumor necrosis factor with modified channel activity |
| 09/16/1993 | WO1993018147A1 Protein compound capable of inhibiting tumoral growth |
| 09/16/1993 | WO1993018146A2 Proteins forming complexes with chaperones and ligands thereof, fragments thereof, preparation thereof and biological uses thereof |
| 09/16/1993 | WO1993018145A1 INSECTICIDAL TOXINS FROM THE PARASITIC WASP $i(BRACON HEBETOR) |
| 09/16/1993 | WO1993018143A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | WO1993018141A1 Thrombin receptor antagonists |
| 09/16/1993 | WO1993018066A1 Neurotrophic factors having altered receptor binding specificities |
| 09/16/1993 | WO1993018065A1 Physiologically active proteinaceous substance |
| 09/16/1993 | WO1993018064A1 Endothelial cell-derived differentiation modulating factors, their preparation and use |
| 09/16/1993 | WO1993018061A1 Immunostimulatory agent |
| 09/16/1993 | WO1993018055A2 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 09/16/1993 | WO1993018054A2 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/16/1993 | WO1993018047A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
| 09/16/1993 | WO1993017776A1 Method of preparing fibrinogen |
| 09/16/1993 | WO1993017719A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
| 09/16/1993 | WO1993017717A1 Compositions and methods for modulating rna |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017708A1 Method for treating macrophage pathogen infections |
| 09/16/1993 | WO1993017706A1 Genetic vaccine for immunodeficiency viruses |
| 09/16/1993 | WO1993017705A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 09/16/1993 | WO1993017703A1 Methods and compositions for the modulation of host immune response to allergens |
| 09/16/1993 | WO1993017701A1 Endothelin receptor-binding peptides |
| 09/16/1993 | WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 09/16/1993 | WO1993017699A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | WO1993017693A1 Albumin-iodine preservation of blood, tissues and biological fluids |
| 09/16/1993 | WO1993017108A3 Analogous peptides of the internal image of a viral protein |